Microbubbles as ultrasound triggered drug carriers

Journal of Pharmaceutical Sciences

Volumn 98, Issue 6, 2009, Pages 1935-1961

  Tinkov, Steliyan ^a   Bekeredjian, Raffi ^b   Winter, Gerhard ^a   Coester, Conrad ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Formulation; Microbubbles; Molecular targeting; Nonviral gene delivery; Quality control; Targeted drug delivery; Ultrasound

Indexed keywords

ALBUNEX; ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA INTERFERON; BLOOD CLOTTING FACTOR 9; BR 14; CARDIOSPHERE; DNA; DRUG CARRIER; ECHOVIST; HEXOKINASE 1; HUMAN INSULIN; LIPOPLEX; PERFLEXANE; PERFLUBUTANE; PERFLUOROPENTANE; PERFLUTREN; PESDA; QUANFUXIAN; QUANTISON; SHU 508; SMAD7 PROTEIN; SONOVIST; SONOVUE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTERY INTIMA PROLIFERATION; CONTRAST ENHANCEMENT; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; DRUG MANUFACTURE; DRUG QUALITY; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG SAFETY; DRUG TARGETING; EMULSION; EPITHELIUM HYPERPLASIA; GENE TRANSFER; GENETIC TRANSFECTION; HEART MUSCLE ISCHEMIA; HEMOPHILIA; HUMAN; HYDROGEN BOND; IMMUNOGENICITY; KIDNEY FIBROSIS; LIVER CELL CARCINOMA; MICROBUBBLE; MOLECULAR INTERACTION; MUSCLE ISCHEMIA; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; QUALITY CONTROL; REVIEW; SCIENTIST; SPRAY DRYING; TRANSGENE; TREATMENT OUTCOME; ULTRASOUND; ZETA POTENTIAL;

EID: 67049136376     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21571     Document Type: Review

References (186)

1. De Jong N, Frinking PJ, Bouakaz A, Cate FJ. 2000. Detection procedures of ultrasound contrast agents. Ultrasonics 38:87-92. (Pubitemid 30592603)
2. Gramiak R, Shah PM. 1968. Echocardiography of the aortic root. Invest Radiol 3:356-366.
3. Pitt WG, Husseini GA, Staples BJ. 2004. Expert opinion on ultrasound drug delivery - A general review. Expert Opin Drug Deliv 1:37-56.
4. Huber PE, Pfisterer P. 2000. In-vitro and in-vivo transfection of plasmid DNA in the dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound. Gene Ther 7:1516-1525. (Pubitemid 30738557)
5. Miller DL, Bao S, Gres RA, Thrall BD. 1999. Ultrasonic enhancement of gene transfection in murine melanoma tumors. Ultrasound Med Biol 25:1425-1430. (Pubitemid 29528383)
6. Anwer K, Kao G, Proctor B, Anscombe I, Florack V, Earls R, Wilson E, McCreery T, Unger E, Rolland A, Sullivan SM. 2000. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther 7:1833-1839.
7. Hosseinkhani H, Aoyama T, Ogawa O, Tabata Y. 2003. Ultrasound enhances the transfection of plasmid DNA by non-viral vectors. Curr Pharmaceut Biotechnol 4:109-122. (Pubitemid 36416868)
8. Mukherjee D, Wong J, Griffin B, Ellis SG, Porter T, Sen S, Thomas JD. 2000. Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. J Am Coll Cardiol 35:1678-1686. (Pubitemid 30307516)
9. Zderic V, Vaezy S, Martin RW, Clark JI. 2002. Ocular drug delivery using 20-kHz ultrasound. Ultrasound Med Biol 28:823-829. (Pubitemid 34759991)
10. O'Brien WD. 2007. Ultrasound - Biophysics mechanisms. Progr Biophys Mol Biol 93:212-255.
11. United States Food and Drug Administration. 1997. Information for manufacturers seeking marketing clearance of diagnostic ultrasound systems and transducers.
12. Miller DL, Quddus J. 2000. Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies. Ultrasound Med Biol 26:661-667. (Pubitemid 30336669)
13. Miller DL, Pislaru SV, Greenleaf JF. 2002. Sonoporation: Mechanical DNA delivery by ultrasonic cavitation. Som Cell Mol Genet 27:115-134.
14. Marmottant P, Hilgenfeldt S, Versluis M, Gardeniers H, van den Berg A, Lohse D. 2004. Cell permeabilisation and transport focused around oscillating microbubbles. Proceedings of the XXI International Congress of Theoretical and Applied Mechanics. Poland: Warsaw.
15. Marmottant P, Hilgenfeldt S. 2003. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature 423:152-156. (Pubitemid 36569534)
16. Barnett S. 1998. Nonthermal issues: Cavitation - Its nature, detection and measurement. Ultrasound Med Biol 24:11-21. (Pubitemid 128713211)
17. Guzman HR, McNamara AJ, Nguyen DX, Prausnitz MR. 2003. Bioeffects caused by changes in acoustic cavitation bubble density and cell concentration: A unified explanation based on cell-to-bubble ratio and blast radius. Ultrasound Med Biol 29:1211-1222. (Pubitemid 37011234)
18. Wang ZQ, Pecha R, Gompf B, Eisenmenger W. 1999. Single bubble sonoluminescence: Investigations of the emitted pressure wave with a fiber optic probe hydrophone. Phys Rev E 59:1777-1780. (Pubitemid 129309731)
19. Wei W, Zheng-Zhong B, Yong-Jie W, Qing-Wu Z, Ya-Lin M. 2004. Bioeffects of low-frequency ultrasonic gene delivery and safety on cell membrane permeability control. J Ultrasound Med 23:1569-1582. (Pubitemid 39586862)
20. Juffermans L, Dijkmans PA, Musters RJ, Visser CA, Kamp O. 2006. Transient permeabilization of cell membranes by ultrasound-exposed microbubbles is related to formation of hydrogen peroxide. Am J Physiol Heart Circ Physiol 291:1595-1601. (Pubitemid 44497663)
21. Miller DL, Thomas RM. 1993. A comparison of hemolytic and sonochemical activity of ultrasonic cavitation in a rotating tube. Ultrasound Med Biol 19:83-90. (Pubitemid 23088699)
22. Lawrie A, Brisken AF, Francis SE, Cumberland DC, Crossman DC, Newman CM. 2000. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther 7:2023-2027. (Pubitemid 32036768)
23. Lawrie A, Brisken AF, Francis SE, Wyllie D, Kiss-Toth E, Qwarnstrom EE, Dower SK, Crossman DC, Newman CM. 2003. Ultrasound-enhanced transgene expression in vascular cells is not dependent upon cavitation-induced free radicals. Ultrasound Med Biol 29:1453-1461. (Pubitemid 37345158)
24. Bouakaz A, Tran TA, Roger S, Leguennec JY, Tranquart F. 2006. On the mechanisms of cell membrane permeabilization with ultrasound and microbubbles. Ultrasound Med Biol 32:90.
25. Schlicher RK, Radhakrishna H, Tolentino TP, Apkarian RP, Zarnitsyn V, Prausnitz MR. 2006. Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol 32:915-924. (Pubitemid 43903070)
26. Deng CX, Sieling F, Pan H, Cui J. 2004. Ultrasound-induced cell membrane porosity. Ultrasound Med Biol 30:519-526. (Pubitemid 38581152)
27. McNeil PL, Terasaki M. 2001. Coping with the inevitable: How cells repair a torn surface membrane. Nat Cell Biol 3:124-129. (Pubitemid 32422077)
28. Pan H, Zhou Y, Izadnegahdar O, Cui J, Deng CX. 2005. Study of sonoporation dynamics affected by ultrasound duty cycle. Ultrasound Med Biol 31:849-856. (Pubitemid 40776083)
29. Kudo K, Yamamoto K. 2005. Behaviour of microbubbles exposed to pulsed ultrasound and their mechanical effect on a cell. Proceedings of the 4th National Symposium on Therapeutic Ultrasound. Melville, NY: American Institute of Physics.
30. Duvshani-Eshet M, Baruch L, Kesselman E, Shimoni E, Machluf M. 2006. Therapeutic ultrasound-mediated DNA to cell and nucleus: Bioeffects revealed by confocal and atomic-force microscopy. Gene Ther 13:163-172. (Pubitemid 43039908)
31. Duvshani-Eshet M, Adam D, Machluf M. 2006. The effects of albumin-coated microbubbles in DNA delivery mediated by therapeutic ultrasound. J Control Release 112:156-166.
32. Jacobsen JÅ, Oyen R, Thomsen HS, Morcos SK. 2005. Safety of ultrasound contrast agents. Eur Radiol 15:941-945. (Pubitemid 41174436)
33. Albrecht T, Blomley M, Bolondi L, Claudon M, Correas JM, Cosgrove D, Greiner L, Jäger K, de Jong N, Leen E, Lencioni R, Lindsell D, Martegani A, Solbiati L, Thorelius L, Tranquart F, Weskott HP, Whittingham T. 2004. European Federation of Societies for Ultrasound in Medicine and Biology Study Group (EFSUMB) guidelines for the use of contrast agents in ultrasound. Ultraschall in der Medizin 25:249-256.
34. Tranquart F, Claudon M, Correas JM. 2005. Guidelines for the use of contrast agents in ultrasound. J Radiol 86:1047-1054. (Pubitemid 41232759)
35. Rapoport N, Gao Z, Kennedy A. 2007. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 99:1095-1106. (Pubitemid 47241394)
36. Food and Drug Administration. 1994. Use of mechanical index in place of spatial peak, pulse average intensity in determining substantial equivalence. Rockville, MD: Center for Devices and Radiological Health. Food and Drug Administration, US Department of Health and Human Services.
37. De Jong N. 2002. Mechanical index. Eur J Echocardiography 3:73-74. (Pubitemid 34732730)
38. Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, Correas JM, Darge K, Dietrich C, D'Onofrio M, Evans DH, Filice C, Greiner L, Jäger K, de Jong N, Leen E, Lencioni R, Lindsell D, Martegani A, Meairs S, Nolsøe C, Piscaglia F, Ricci P, Seidel G, Skjoldbye B, Solbiati L, Thorelius L, Tranquart F, Weskott HP, Whittingham T. 2008. Guidelines and Good Clinical Practice recommendations for contrast enhanced ultrasound - Update 2008. Ultraschall Med 29:28-44. (Pubitemid 351294171)
39. Hlinomazova Z, Hrazdira I. 2005. ALARA - Principle and safety problems of diagnostic ultrasound. Scripta Medica (Brno) 78:341-346. (Pubitemid 44317488)
40. Tsunoda S, Mazda O, Oda Y, Iida Y, Akabame S, Kishida T, Shin-Ya M, Asada H, Gojo S, Imanishi J, Matsubara H, Yoshikawa T. 2005. Sonoporation using BR14 promotes pDNA/siRNA transduction to murine heart. Biochem Biophys Res Comm 336:118-127. (Pubitemid 41253411)
41. Koike H, Tomita N, Azuma H, Taniyama Y, Yamasaki K, Kunugiza Y, Tachibana K, Ogihara T, Morishita R. 2005. An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J Gene Med 7:108-116.
42. Azuma H, Tomita N, Kaneda Y, Koike H, Ogihara T, Katsuoka Y, Morishita R. 2003. Transfection of NF-kappa B-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Gene Ther 10:415-425. (Pubitemid 36372449)
43. Christiansen JP, French BA, Klibanov AL, Kaul S, Lindner JR. 2003. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol 29:1759-1767. (Pubitemid 38091725)
44. Zwiorek K, Kloeckner J, Wagner E, Coester C. 2004. Gelatin nanoparticles as a new and simple gene delivery system. J Pharm Pharmaceut Sci 7:22-28. (Pubitemid 41522055)
45. Christiansen JP, Leong-Poi H, Klibanov AL, Kaul S, Lindner JR. 2002. Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation 105:1764-1767. (Pubitemid 34408882)
46. Lindner JR, Coggins MP, Kaul S, Klibanov AL, Brandenburger GH, Ley K. 2000. Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leucocytes. Circulation 101:668-675. (Pubitemid 30094739)
47. Bloch S, Dayton P, Ferrara K. 2004. Targeted imaging using ultrasound contrast agents. IEEE Eng Med Biol Mag 23:18-29. (Pubitemid 39545964)
48. Siwak DR, Tary AM, Lopez-Berestein G. 2002. The potential of drug-carrying immunoliposomes as anticancer agents. Clin Cancer Res 8:955-956. (Pubitemid 35177341)
49. Shi M, Wosnik JH, Ho K, Keating A, Shoichet MS. 2007. Immuno-polymeric nanoparticles by Diels-Alder chemistry. Angew Chem Int Ed 46:6126-6131. (Pubitemid 47290969)
50. Lim AKP, Patel N, Eckersley RJ, Taylor-Robinson SD, Cosgrove DO, Blomley MJ. 2004. Evidence for spleen-specific uptake of a microbubble contrast agent: A quantitative study in healthy volunteers. Radiology 231:785-788. (Pubitemid 38668098)
51. Wheatley MA, Lathia JD, Oum KL. 2007. Polymeric ultrasound contrast agents targeted to integrins: Importance of process methods and surface density of ligands. Biomacromolecules 8:516-522. (Pubitemid 46323268)
52. Klibanov AL, Gu H, Wojdyla JK, Wible JH, Kim DH, Needham D, Villanueva FS, Brandenburger GH. 1999. Attachment of ligands to gas-filled microbubbles via PEG-spacer and lipid residues anchored at the interface. Proc Int Symp Control Rel Bioact Mater: 26.
53. Rychak JJ, Lindner JR, Ley K, Klibanov AL. 2006. Deformable gas-filled microbubbles targeted to P-selectin. J Control Release 114:288-299. (Pubitemid 44310816)
54. Rychak JJ, Ley K, Klibanov A, Hossack J. 2005. Acoustic radiation force enhances ultrasound contrast agents retention to P-selectin in-vivo. IEEE Ultrason Symp 3:1703-1707. (Pubitemid 46285149)
55. Shortencarier MJ, Dayton PA, Bloch SH, Schumann PA, Matsunaga TO, Ferrara KW. 2004. A method for force localized drug delivery using gasfilled lipospheres. IEEE Transac Ultrasonics Ferroelectr Freq Control 51:822-831.
56. Dayton P, Klibanov A, Brandenburger G, Ferrara K. 1999. Acoustic radiation force in-vivo: A mechanism to assist targeting of microbubbles. Ultrasound Med Biol 25:1195-1201. (Pubitemid 29465793)
57. Borden MA, Zhang H, Gillies RJ, Dayton PA, Ferrara KW. 2008. A stimulus-responsive ultrasound contrast agents for molecular imaging. Biomaterials 29:597-606. (Pubitemid 350100802)
58. Borden MA, Sarantos M, Stieger S, Simon S, Ferrara KW, Dayton PA. 2006. Ultrasound radiation force modulates ligand availability on targeted contrast agents. Mol Imaging 5:139-147.
59. Lanza GM, Wickline SA. 2001. Targeted ultrasonic contrast agents for molecular imaging and therapy. Progr Cardiovasc Dis 44:13-31. (Pubitemid 32807852)
60. Klibanov AL. 1999. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv Drug Deliv Rev 37:139-157. (Pubitemid 29164505)
61. Wickline SA, Lanza GM. 2002. Molecular imaging, targeted therapeutics, and nanoscience. J Cell Biochem (Suppl) 39:90-97. (Pubitemid 36176561)
62. Lanza GM, Wickline SA. 2001. Targeted ultrasonic contrast agents for molecular imaging and therapy. Progr Cardiovasc Dis 44:13-31. (Pubitemid 32807852)
63. Klibanov AL. 2007. Targeted microbubbles: Ultrasound contrast agents for molecular imaging. In: Bulte JW, Modo MM, editors. Nanoparticles in biomedical immaging. New York: Springer. pp. 327-341.
64. Hall ML. 2003. Modeling drug albumin binding affinity with e-state topological structure representation. J Chem Inf Comput Sci 43:2120-2128.
65. Zuhorn IS, Bakowski U, Polushkin E, Visser WH, Stuart MC, Engberts JB, Hoekstra D. 2005. Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency. Mol Ther 11:801-811. (Pubitemid 40567984)
66. Kim DH, Costello MJ, Duncan PB, Needham D. 2003. Mechanical properties and microstructure of polycrystalline phospholipid monolayer shells: Novel solid microparticles. Langmuir 19:8455-8466.
67. Borden MA, Martinez GV, Ricker J, Tsvetkova N, Longo M, Gillies RJ, Dayton PA, Ferrara KW. 2006. Lateral phase separation in lipid-coated microbubbles. Langmuir 22:4291-4297.
68. Borden MA, Dayton P, Zhao S, Ferrara KW. 2004. Physico-chemical properties of the microbubble lipid shell. IEEE Ultrasonics Symp 1:20-23.
69. Duncan PB, Needham D. 2004. Test of the Epstein-Plesset model for gas microparticle dissolution in aqueous media: Effect of surface tension and gas undersaturation in solution. Langmuir 20:2567-2578.
70. Borden MA, Longo ML. 2004. Oxygen permeability of fully condensed lipid monolayers. J Phys Chem B 108:6009-6016.
71. Borden MA, Longo ML. 2002. Dissolution behavior of lipid monolayer-coated, air-filled microbubbles: Effect of lipid hydrophobic chain length. Langmuir 18:9225-9233. (Pubitemid 35458180)
72. Pu G, Longo ML, Borden MA. 2005. Effect of microstructure on molecular oxygen permeability through condensed phospholipid monolayers. J Am Chem Soc 127:6524-6525. (Pubitemid 40664146)
73. Möhwald H. 1995. Phospholipid monolayers. In: Lipowski R, Sackmannn E, editors. Handbook of biological physics, Vol.1. Amsterdam: Elsevier. pp. 161-211.
74. Forsberg F, Lathia JD, Merton DA, Liu JB, Le NT, Goldberg BB, Wheatley MA. 2004. Effect of shell type on the in-vivo backscatter from polymerencapsulated microbubbles. Ultrasound Med Biol 30:1281-1287. (Pubitemid 39576179)
75. Epstein PS, Plesset MS. 1950. On the stability of gas bubbles in liquid-gas solutions. J Chem Phys 18:1505-1509.
76. Kabalnov A, Bradley J, Flaim S, Klein D, Pelura T, Peters B, Otto S, Reynolds J, Schutt E, Weers J. 1998. Dissolution of multicomponent microbubbles in the bloodstream: 2. Experiment. Ultrasound Med Biol 24:751-760. (Pubitemid 28285211)
77. Schutt EG, Klein DH, Mattrey RM, Riess JG. 2003. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: The key role of perfluorochemicals. Angew Chem Int Ed 42:3218-3235. (Pubitemid 36917164)
78. Forsberg F, Basude R, Liu JB, Alessandro J, Shi WT, Rawool NM, Goldberg BB, Wheatley MA. 1999. Effect of filling gases on the backscatter from contrast microbubbles: Theory and in-vivo measurements. Ultrasound Med Biol 25:1203-1211. (Pubitemid 29465794)
79. Schutt EG, Evitts DP, Kinner RA, Anderson CD, Weers JG. 2004. Osmotically stabilized microbubble preparations. United States Patent 6706253.
80. Unger EC. 2002. Acoustically active drug delivery systems. United States Patent No.: US 6,416,740 B1.
81. Schneider M, Bichon D, Bussat P, Puginier J, Hybl E. 1991. Ultrasound contrast agents and methods of making and using them. Patent WO 91/15244.
82. El-Sherif DM, Wheatley MA. 2003. Development of a novel method for synthesis of a polymeric ultrasound contrast agent. J Biomed Mater Res 66A: 347-355. (Pubitemid 37517235)
83. Short RE. 2005. Method of preparing gas filled polymer matrix microparticles useful for echographic imaging. United States Patent No.: US 6,919,068 B2.
84. Ottoboni TB, Short RE, Yamamoto RK. 2001. Microparticles useful as ultrasonic contrast agents. United States Patent No.: US 6,193,951 B1.
85. Burstein OM, Forsberg F, Liu JB, Merton D, Wheatley MA. 2005. Hydrophobic drug loaded contrast agents: Effects on enhancement. Proceedings of the IEEE 31st Annual Northeast Bioengineering Conference: 140-141.
86. Seemann S, Hauff P, Schultze-Mosgau M, Lehmann C, Reszka R. 2002. Pharmaceutical evaluation of gas-filled microparticles as gene delivery system. Pharmaceut Res 19:250-257. (Pubitemid 34211840)
87. Narayan P, Marchant D, Wheatley MA. 2001. Optimization of spray drying by factorial design for production of hollow microspheres for ultrasound imaging. J Biomed Mater Res 56:333-341. (Pubitemid 32611883)
88. Shutt EG. 1996. Harmonic ultrasound imaging with microbubbles. United States Patent No.: US 5,540,909.
89. Tsapis N, Dufresne ER, Sinha SS, Riera CS, Hutchinson JW, Mahadevan L, Weitz DA. 2005. Onset of buckling in drying droplets of colloidal suspensions. Phys Rev Lett 94:0183021-0183024.
90. Sano Y, Keey RB. 1982. The drying of spherical particle containing colloidal material into a hollow sphere. Chem Eng Sci 37:881-889.
91. Goldberg B. 1997. Ultrasound contrast agents. London: Martin Dunitz.
92. Bodmeier R, Chen H. 1988. Preparation of biodegradable poly-(±)lactide microparticles using a spray-drying technique. J Pharmaceut Pharmacol 40:754-757. (Pubitemid 18274058)
93. Talu E, Hettiarachchi K, Nguyen H, Lee AP, Powell RL, Longo ML, Dayton PA. 2006. Lipid-stabilized monodisperse microbubbles produced by flow focusing for use as ultrasound contrast agents. IEEE Ultrason Symp: 1568-1571.
94. Schmidt W, Roessling G. 2006. Novel manufacturing process of hollow polymer microspheres. Chem Eng Sci 61:4973-4981. (Pubitemid 43815813)
95. Leong-Poi H, Kuliszewski MA, Lekas M, Sibbald M, Teichert-Kuliszewska K, Klibanov AL, Stewart DJ, Lindner JR. 2007. Therapeutic arteriogenesis by ultrasounbd-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ Res 101:295-303. (Pubitemid 47344079)
96. Lentacker I, de Smedt SC, Demeester J, Sanders NN. 2006. Microbubles which bind and protect DNA against nucleases. J Control Release 116:e73-e75.
97. Kinoshita T. 2001. The method to determine the optimum refractive index parameter in the laser diffraction and scattering method. Adv Powder Tech 12:589-602. (Pubitemid 34080661)
98. Cavalieri F, Hamassi AE, Chiessi E, Paradossi G. 2005. Stable polymeric microballoons as multifunctional device for biomedical uses: Synthesis and characterization. Langmuir 21:8758-8764. (Pubitemid 41396634)
99. Cavalieri F, Hamassi AE, Chiessi E, Paradossi G, Villa R, Zaffaroni N. 2006. Ligands tethering to biocompatible ultrasound active polymeric microbubbles surface. Macromol Symp 234:94-101.
100. Fisher NG, Christiansen JP, Klibanov AL, Taylor RP, Kaul S, Lindner JR. 2002. Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. J Am Coll Cardiol 40:811-819. (Pubitemid 34925631)
101. Männistö M, Vanderkerken S, Toncheva V, Elomaa M, Ruponen M, Schacht E, Urtti A. 2002. Structure-activity relationschips of poly-llysines: Effects of PEGylation and molecular shape on physicochemical and biological properties in gene delivery. J Control Release 83:169-182. (Pubitemid 35239824)
102. Postema M, van Wamel A, Lancée CT, de Jong N. 2004. Ultrasound-induced encapsulated microbubble phenomena. Ultrasound Med Biol 30:827-840. (Pubitemid 38829548)
103. Sboros V, Glynos E, Pye SD, Moran CM, Butler M, Ross J, Short R, McDicken WN, Koutsos V. 2006. Nanointerrogation of ultrasonic contrast agent microbubbles using atomic force microscopy. Ultrasound Med Biol 32:579-585.
104. Bloch SH, Wan M, Dayton PA, Ferrara KW. 2004. Optical observation of lipid- and polymer-shelled ultrasound microbubble contrast agents. Appl Phys Lett 84:631-633.
105. Lazewatsky J, Kagan M, Barrett JA. 1999. The effect of dilution medium on the measurement of in-vitro properties of ultrasound contrast agents. IEEE Ultrason Symp 2:1737-1742.
106. Marsh JN, Hall CS, Scott MJ, Fuhrhop RW, Gaffney PJ, Wickline SA, Lanza GM. 2002. Improvements in the uultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model. IEEE Trans Ultrason Ferroelectrics Freq Contr 4:29-38. (Pubitemid 34491242)
107. Moran CM, Anderson T, Pye SD, Sboros V, McDicken WN. 2000. Quantification of microbubble destruction of three fluorocarbon-filled ultrasonic contrast agents. Ultrasound Med Biol 26:629-639. (Pubitemid 30336665)
108. Borden MA, Pu G, Runner GJ, Longo ML. 2004. Surface phase behavior and microstructure of lipid/PEG-emulsifyer monolayer-coated microbubbles. Colloids Surf B Biointerfaces 35:209-223. (Pubitemid 38681222)
109. Hvattum E, Uran S, Sandbæk AG, Karlsson AÅ, Skotland T. 2006. Quantification of phosphatidylserine, phosphatidic acid and free fatty acids in an ultrasound contrast agent by normal-phase high-performance liquid chromatography with evaporative light scattering detection. J Pharmaceut Biomed Anal 42:506-512. (Pubitemid 44375102)
110. http://wiley.co.uk/genetherapy/clinical/
111. Crystal RG. 1995. Transfer of genes to humans: Early lessons and obstacles to success. Science 270:404-410.
112. Raper SE, Yudkoff M, Chirmule N, Gao GP, Nunes F, Haskal ZJ, Furth EE, Propert KJ, Robinson MB, Magosin S, Simoes H, Speicher L, Hughes J, Tazelaar J, Wivel NA, Wilson JM, Batshaw ML. 2002. A pilot study of in-vivo liver-directed gene transfer with an adenoviral vector in partial ornitine transcarbamylase deficiency. Hum Gene Ther 13:163-175. (Pubitemid 34075180)
113. Boulaiz H, Marchal JA, Prados J, Melguizo C, Aranega A. 2005. Non-viral and viral vectors for gene therapy. Cell Mol Biol 51:3-22. (Pubitemid 43093388)
114. Newman CM, Bettinger T. 2007. Gene therapy progress and prospects: Ultrasound for gene transfer. Gene Ther 14:465-475. (Pubitemid 46390919)
115. Akowuah EF, Gray C, Lawrie A, Sheridan PJ, Su CH, Bettinger T, Brisken AF, Gunn J, Crossman DC, Francis SE, Baker AH, Newman CM. 2005. Ultrasound-mediated delivery of TIMP-3 plasmid DNAinto saphenous vein leads to increased lumen size in a porcine interposition graft model. Gene Ther 12:1154-1157. (Pubitemid 41030621)
116. Endoh M, Koibuchi N, Sato M, Morishita R, Kanzaki T, Murata Y, Kaneda Y. 2002. Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound. Mol Ther 5:501-508. (Pubitemid 34546079)
117. Erikson JM, Freeman GL, Chandrasekar B. 2003. Ultrasound-targeted antisense oligonucleotide attenuates ischemia/reperfusion-induced myocardial tumor necrosis factor-alpha. J Mol Cell Cardiol 35:119-130. (Pubitemid 36286974)
118. Lan HY, Mu W, Tomita N, Huang XR, Li JH, Zhu HJ, Morishita R, Johnson RJ. 2003. Inhibition of renal fibrosis by gene transfer of inducible smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 14:1535-1548. (Pubitemid 36687055)
119. Taniyama Y, Tachibana K, Hiraoka K, Aoki M, Yamamoto S, Matsumoto K, Nakamura T, Ogihara T, Kaneda Y, Morishita R. 2002. Development of safe and efficient novel nonviral gene transfer using ultrasound: Enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 9:372-380. (Pubitemid 34414035)
120. Lu QL, Liang HD, Partridge T, Blomley MJ. 2003. Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in-vivo with reduced tissue damage. Gene Ther 10:396-405. (Pubitemid 36372447)
121. Pislaru SV, Pislaru C, Kinnick RR, Singh R, Gulati R, Greenleaf JF, Simari RD. 2003. Optimization of ultrasound-mediated gene transfer: Comparison of contrast agents and ultrasound modalities. Eur Heart J 24:1690-1698. (Pubitemid 37174910)
122. Sakakima Y, Hayashi S, Yagi Y, Hayakawa A, Tachibana K, Nakao A. 2005. Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents. Cancer Gene Ther 12:884-889. (Pubitemid 41487029)
123. Miao CH, Brayman AA, Loeb KR, Ye P, Zhou L, Mourad P. 2005. Ultrasound enhances gene delivery of human factor IX plasmid. Hum Gene Ther 16:893-905. (Pubitemid 40982337)
124. Miller DL, Song J. 2003. Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in-vivo. Ultrasound Med Biol 29:887-893. (Pubitemid 36808641)
125. Lee R. 2000. Water-insoluble drug formulation. Boca Raton, USA: Taylor & Francis Group. pp. 455-490.
126. Apfel RE, Holland CK. 1991. Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. Ultrasound Med Biol 17:179-185.
127. Nanda NC, Carstensen EL. 1997. Echo-enhancing agents: Safety. In: Nanda NC, Schlief R, Goldberg BB, editors. Advances in echo imaging using contrast enhancers. Dordrecht, The Netherlands: Kluwer. pp. 115-131.
128. Yamaya Y, Niizeki K, Kim J, Entin PL, Wagner H, Wagner PD. 2002. Effects of Optison® on pulmonary gas exchange and hemodynamics. Ultrasound Med Biol 28:1005-1013. (Pubitemid 36158836)
129. Miller DL, Li P, Dou C, Gordon D, Edwards CA, Armstrong WF. 2005. Influence of contrast agent dose and ultrasound exposure on cardiomyocyte injury induced by myocardial contrast echocardiography in rats. Radiology 237:137-143. (Pubitemid 41346157)
130. Chapman S, Windle J, Xie F, McGrain A, Porter TR. 2005. Incidence of cardiac arrhythmias with therapeutic versus diagnostic ultrasound and intravenous microbubbles. J Ultrasound Med 24:1099-1107. (Pubitemid 41061462)
131. Porter TR. 1997. Perfluorobutane ultrasound contrast agent and methods for its manufacture and use. Board of Regents of the University of Nebraska. US Patent, US 5,567,415.
132. Chi DS, Liu YL, Wang P, Chen XL, Liu J, Xie ZB, Li Q, Ou WC, Xiu JC, Zha DG, Wu PS, Xu DL. 2003. Value of echocardiography for observing left ventricular hypertrophy in the diagnosis of myocardial microvascular damage in hypertensives. Di Yi Jun Yi Da Xue Xue Bao 23:702-705.
133. Blomley M, Claudon M, Cosgrove D. 2007. World federation for ultrasound in medicine and biology (WFUMB) safety symposium on ultrasound contrast agents: Clinical applications and safety concerns. Ultrasound Med Biol 33:180-186.
134. Krestan C. 2005. Ultraschallkontrastmittel: Substanzklassen, Pharmakokinetik, klinische Anwendungen, Sicherheitsaspekte. Radiologe 45:513-519. (Pubitemid 40941785)
135. Ultrasound technology information portal, ultrasound database, http://www.us-tip.com.
136. Skyba D, Price R, Linka A, Skalak T, Kaul S. 1998. Direct in-vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 98:290-293. (Pubitemid 28348049)
137. Li P, Cao LQ, Dou CY, Armstrong WF, Miller D. 2003. Impact of myocardial contrast echocardiography on vascular permeability: An in-vivo dose response study of delivery mode, pressure amplitude and contrast dose. Ultrasound Med Biol 29:1341-1349. (Pubitemid 37211334)
138. Song J, Chappell JC, Qi M, VanGieson EJ, Kaul S, Price RJ. 2002. Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres in muscle. J Am Coll Cardiol 39:726-731. (Pubitemid 34158172)
139. Price RJ, Skyba DM, Kaul S, Skalak TC. 1998. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 98:1264-1267. (Pubitemid 28443388)
140. Imada T, Tatsumi T, Mori Y, Nishiue T, Yoshida M, Masaki H, Okigaki M, Kojima H, Nozawa Y, Nishiwaki Y, Nitta N, Iwasaka T, Matsubara H. 2005. Targeted delivery of bone marrow mononuclear cels by ultrasound destruction of microbubbles induces both angiogenesis and arteriogenesis response. Arterioscler Thromb Vasc Biol 25:2128-2134. (Pubitemid 41416311)
141. Stieger SM, Caskey CF, Adamson RH, Qin S, Curry FR, Wisner ER, Ferrara KW. 2007. Enhancement of vascular permeability with low-frequency contrast-enhanced ultrasound in the chorioallantoic membrane model. Radiology 243:112-121. (Pubitemid 46579701)
142. Sheikov N, McDannold N, Vykhodtseva N, Jolesz F, Hynynen K. 2004. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasouond Med Biol 30:979-989. (Pubitemid 39094314)
143. Shimamura M, Sato N, Taniyama Y, Yamamoto S, Endoh M, Kurinami H, Aoki M, Ogihara T, Kaneda Y, Morishita R. 2004. Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound. Gene Ther 11:1532-1539. (Pubitemid 39359461)
144. Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K. 2007. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 121:901-907.
145. Unger EC, McCreery T, Sweitzer R, Vielhauer G, Guan-Li W, Shen D, Yellowhair D. 1998. MRX 501: A novel ultrasound contrast agent with therapeutic properties. Acad Radiol 5:247-249.
146. Bekeredjian R, Chen S, Frenkel P, Grayburn P, Shohet R. 2003. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expresssion to the heart. Circulation 108:1022-1026. (Pubitemid 37048235)
147. Vannan M, McCreery T, Li P, Han Z, Unger E, Kuersten B, Nabel E, Rajagopalan S. 2002. Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. J Am Soc Echocardiogr 15:214-218. (Pubitemid 44964512)
148. Bekeredjian R, Chen S, Grayburn P, Shohet R. 2005. Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. Ultrasound Med Biol 31:687-691. (Pubitemid 40615188)
149. Bekeredjian R, Kuecherer HF, Kroll RD, Katus HA, Hardt SE. 2007. Ultrasound-targeted microbubble destruction augments protein delivery into testes. Urology 69:386-389. (Pubitemid 46274954)
150. Tartis MS, McCallan J, Lum A, LaBell R, Stieger SM, Matsunaga TO, Ferrara KW. 2006. Therapeutic effects of paclitaxel-containing ultrasound contrasts agents. Ultrasound Med Biol 32:1771-1780. (Pubitemid 44716573)
151. Unger E, McCreery T, Sweitzer R, Caldwell V, Wu Y. 1998. Acoustically
152. Shortencarier M, Dayton P, Ferrara K, Matsunaga T, LaBell R, Schumann P. 2005. Targeted chemotherapy delivery with ultrasound. Institute of Electrical and Electronics Engineers (IEEE) Proceedings: 265-268. (Pubitemid 46285425)
153. Fang JY, Hung CF, Liao MH, Chien CC. 2007. A study of the formulation design of acoustically active lipospheres as carriers for drug delivery. Eur J Pharm Biopharm 67:67-75. (Pubitemid 46991333)
154. Hauff P, Seemann S, Reszka R, Schultze-Mosgau M, Reinhardt M, Buzasi T, Plath T, Rosewisz S, Schirner M. 2005. Evaluation of gas-filled microparticles and sonoporation as gene delivery system: Feasibility study in rodent tumor models. Radiology 236:572-578. (Pubitemid 41023442)
155. Burstein OM, Wheatley MA. 2006. Drug loaded contrast agents for cancer tumors: A combination of imaging and therapy. Biomedical Technology Showcase, July 20th 2006. Drexel University, PA: School of Biomedical Engineering, Science. Health Systems, http://idea.library.drexel.edu/handle/1860/962.
156. Kheirolomoom A, Dayton P, Lum A, Little E, Paoli E, Zheng H, Ferrara K. 2007. Acoustically-active microbubbles conjugated to liposomes: Characterization of a proposed drug delivery vehicle. J Control Release 118:275-284. (Pubitemid 46441545)
157. Lum A, Borden M, Dayton M, Kruse D, Simon S, Ferrara K. 2006. Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J Control Release 111:128-134. (Pubitemid 43290001)
158. Taylor SL, Rahim AA, Bush NL, Bamber JC, Poter CD. 2007. Targeted retroviral gene delivery using ultrasound. J Gene Med 9:77-87. (Pubitemid 46444485)
159. Howard CM, Forsberg F, Minimo C, Liu JB, Merton DA, Claudio PP. 2006. Ultrasound guided site specific gene delivery system using adenoviral vectors and commercial ultrasound contrast agents. J Cell Physiol 209:413-421.
160. Lentacker I, de Geest BG, Vandenbroucke RE, Peeters L, Demeester J, de Smedt SC, Sanders NN. 2006. Ultrasound-responsive polymer-coated microbubbles that bind and protect DNA. Langmuir 22:7273-7278. (Pubitemid 44366426)
161. Borden M, Little E, Gillies R, Ferrara K. 2007. DNA and polylysine adsorption and multylayer construction onto cationic lipid-coated microbubbles. Langmuir 23:9401-9408. (Pubitemid 47383531)
162. Chen SY, Ding JH, Bekeredjian R, Yang BZ, Shohet RV, Johnston SA, Hohmeier HE, Newgard CB, Grayburn PA. 2006. Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci USA 103:8469-8474. (Pubitemid 43838479)
163. Lentacker I, de Smedt SC, Demeester J, Van Marck V, Bracke M, Sanders NN. 2007. Lipoplex-loaded microbubbles for gene delivery: A trojan horse controlled by ultrasound. Adv Funct Mater 17:1910-1916. (Pubitemid 47291238)
164. Korpanty G, Chen S, Shohet RV, Ding J, Yang B, Frenkel PA, Grayburn PA. 2005. Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles. Gene Ther 12:1305-1312. (Pubitemid 43084486)
165. Frenkel PA, Chen S, Thai T, Shohet RV, Grayburn PA. 2002. DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection invitro. Ultrasound Med Biol 28:817-822. (Pubitemid 34756815)
166. Shohet RV, Chen S, Zhou YT, Wang Z, Meidell RS, Unger RH, Grayburn PA. 2000. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 101:2554-2556. (Pubitemid 30350631)
167. Teupe C, Richter S, Fisslthaler B, Randriamboavonjy V, Ihling C, Fleming I, Busse R, Zeiher AM, Dimmeler S. 2002. Vascular gene transfer of phosphomimetic endothelial nitric oxide synthase (S1177D) using ultrasound-enhanced destruction of plasmid-loaded microbubbles improves vasoreactivity. Circulation 105:1104-1109. (Pubitemid 34212622)
168. Dufrene Y, Barger W, Green J, Lee G. 1997. Nanometerscale surface properties of mixed phospholipid monolayers and bilayers. Langmiur 13:4779-4784. (Pubitemid 127591876)
169. Mehier-Humbert S, Yan F, Frinking P, Schneider M, Guy RH, Bettinger T. 2007. Ultrasound-mediated gene delivery: Influence of contrast agent on transfection. Bioconjugate Chem 18:652-662. (Pubitemid 47010783)
170. Molecular Imaging and Contrast Agent Database, 2007. Air-filled, cross-linked, human serum albumin microcapsules. http://www.ncbi.nlm.nih.gov/ books/bookres.fcgi/micad/Quantison.pdf.
171. May DJ, Allen JS, Ferrara KW. 2002. Dynamics and fragmentation of thick shelled microbubbles. IEEE Trans Ultrason Ferroelectrics Freq Contr 49:1400-1410. (Pubitemid 35250641)
172. Chen S, Shohet RV, Bekeredjian R, Frenkel P, Grayburn PA. 2003. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 42:301-308. (Pubitemid 36851422)
173. Ellegala DB, Leong-Poi H, Carpenter JE, Klibanov AL, Kaul S, Shaffrey ME, Sklenar J, Lindner JR. 2003. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)-beta3. Circulation 108:336-341.
174. Weller GE, Wong MK, Modzelewski RA, Lu E, Klibanov AL, Wagner WR, Villanueva FS. 2005. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 65:533-539.
175. Leong-Poi H, Christiansen J, Klibanov AL, Kaul S, Lindner JR. 2003. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alphav-integrins. Circulation 107:455-460. (Pubitemid 36158049)
176. Takeuchi M, Ogunyankin K, Pandian NG, McCreery TP, Sweitzer RH, Caldwell VE, Unger EC, Avelar E, Sheahan M, Connolly R. 1999. Enhanced visualiation of intravascular and left atrial appendage thrombus with the use of a thrombus targeting ultrasonographic contrast agent (MRX-480A1): In-vivo experimental echocardiographic studies. J Am Soc Echocardiogr 12:1015-1021.
177. Schumann PA, Christiansen JP, Quigley RM, McCreery TP, Sweitzer RH, Unger EC, Lindner JR, Matsunaga TO. 2002. Targeted-microbubble binding selectively to GPIIb/IIIa receptors of platelet thrombi. Invest Radiol 37:587-593. (Pubitemid 35231692)
178. Unger EC, McCreery TP, Sweitzer RH, Shen D, Wu G. 1998. In-vitro studies of a new thrombus-specific ultrasound contrast agent. Am J Cardiol 81:58G-61G. (Pubitemid 28309282)
179. Wright WJ Jr, McCreery TP, Krupinski EA, Lund PJ, Smyth SH, Baker MR, Hulett RL, Unger EC. 1998. Evaluation of new thrombus-specific ultrasound contrast agent. Acad Radiol 5:240-242.
180. Villanueva FS, Jankowski RJ, Klibanov S, Pina ML, Alber SM, Watkins SC, Brandenburger GH, Wagner WR. 1998. Microbubbles targeted to intracellular adhesion molecule-1 bind to activated cornary artery endothelial cells. Circulation 98:1-5. (Pubitemid 28312070)
181. Weller GE, Lu E, Csikari MM, Klibanov AL, Fischer D, Wagner WR, Villanueva FS. 2003. Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intracellular adhesion molecule-1. Circulation 108:218-224. (Pubitemid 36871306)
182. Bachmann C, Klibanov AL, Olson TS, Sonnenschein JR, Rivera-Nieves J, Cominelli F, Ley KF, Lindner JR, Pizarro TT. 2006. Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to non-invasively image experimental Crohn's disease. Gastroenterology 130:8-16. (Pubitemid 43049830)
183. Porter TR, Hiser WL, Kricsfeld D, Deligonul U, Xie F, Iversen P, Radio S. 2001. Inhibition of carotid artery neointimal formation with intravenous microbubbles. Ultrasound Med Biol 27:259-265. (Pubitemid 32318314)
184. Zhigang W, Zhiyu L, Haitao R, Hong R, Qunxia Z, Ailong H, Qi L, Chunjing Z, Hailin T, Lin G. 2004. Ultrasound-mediated microbubble destruction enhances VEGF gene delivery to the infracted myocardium in rats. Clin Imaging 28:395-398. (Pubitemid 39505161)
185. Liu Y, Miyoshi H, Nakamura M. 2006. Encapsulated ultrasound microbubbles: Therapeutic application in drug/gene delivery. J Control Release 114:89-99. (Pubitemid 44128627)
186. Ferrara KW, Pollard R, Borden M. 2007. Ultrasound microbubble contrast agents: Fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 9:415-447. (Pubitemid 350246663)